Second Opinion

SECOND OPINION: BIG PHARMA SQUARELY TO BLAME FOR RISING MEDICARE PREMIUMS

Nov 12, 2019

Drug Makers Cry ‘False Narrative’ Over Latest Repot Highlighting Toll of Read More

Second Opinion: GAO Undermines Common Refrain in Big Pharma’s Blame Game

Aug 16, 2019

Analysis Finds PBMs Pass On Over 99 Percent of Rebates, Used to Keep Premiums Read More

Second Opinion: Correcting Big Pharma’s Claims On The Rebate Rule

Jul 12, 2019

America’s seniors and taxpayers received a huge win today when the Read More

Second Opinion: Boosted Ad Budgets Undercut Big Pharma’s R&D Rhetoric

Apr 17, 2019

New Report Finds Drug Makers Spent Whopping $6.46 Billion On Advertising In Read More

Second Opinion: Rebate Rule Would be Revolutionary … For Big Pharma

Apr 5, 2019

Nothing in Proposed Rule Guarantees Prices Will Come Down by Full Amount of Read More

Second Opinion: Rebate Rule Will Hike Premiums On Seniors

Mar 12, 2019

Lowering prescription drug prices is a laudable focus of the Trump Read More

Second Opinion: R&D Is Not To Blame For Skyrocketing Drug Costs

Jan 17, 2019

The jig is up – a new report showsthat “the skyrocketing cost of many Read More

Second Opinion: No, Big Pharma Is Not Changing

Jan 11, 2019

Right on cue, dozens of pharmaceutical companies rang in the new year by Read More

Second Opinion: Big Pharma’s Back At It

Dec 3, 2018

If at first you don’t succeed try, try again.  That’s the old adage Big Read More

SECOND OPINION: Don’t Be Fooled.  Drug Companies Are Responsible For High Drug Prices

Oct 23, 2018

Repeating the same false claim over and over again doesn’t make it true.  Read More

Second Opinion: The Truth About The Big Pharma Bailout

Sep 25, 2018

In their latest attempt to make billions of dollars on the backs of patients, Read More

SECOND OPINION: Big Pharma Continues Pointing Fingers for Excessive Drug Prices

Sep 12, 2018

Apparently, when it comes to out-of-control drug prices, everyone’s to blame Read More